1. PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma
   Martyn A. Sharpe et al, 2018, Oncotarget CrossRef
2. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
   Marina Ferreira Candido et al, 2023, Pharmaceutics CrossRef